This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

MORNING AFTER (CW33/KDAF) — A company has just finished phase three trials of a monoclonal antibody treatment for COVID-19 and is requesting emergency use authorization for the treatment.

Chairman and CEO of the company Humanigen spoke with the Morning After crew about this treatment.